The North America Photoacoustic Imaging Market would witness market growth of 8.5% CAGR during the forecast period (2023-2030).
Increased acceptance and diagnostic potential are made possible by the integration of photoacoustic imaging capabilities into existing imaging platforms, such as ultrasound devices. Image-guided interventions and tailored medicine may be possible when photoacoustic imaging is combined with targeted therapies or theranostic medicines. Functional imaging capabilities of photoacoustic imaging, such as the ability to track blood flow, tissue oxygenation, and biomarkers, give important insights into disease processes and therapeutic responses, making it a useful tool in personalized medicine.
Although the preclinical phase is crucial for integrating photoacoustic imaging into patient treatment, its significance shouldn't be understated. It directs the creation of novel imaging technologies and applications as well as acts as the basis for technological advancements and scientific publications. Both the preclinical and clinical segments are essential to the market, and each one contributes in its own special way to the development and adoption of the market.
According to the CDC, women in the US are more likely than men to develop cancer. Even though the number of fatalities from breast cancer has declined, it remains the second most frequent cancer in white and Hispanic women. Every year, approximately 264,000 women and 2,400 men in the US get diagnosed with breast cancer. Every year, more than 42,000 women and 500 men in the US pass away from breast cancer. It is anticipated that the increasing prevalence of CKD and cancer will increase the demand for photoacoustic imaging in North America.
The US market dominated the North America Photoacoustic Imaging Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $43,062.8 Thousands by 2030. The Canada market is showcasing a CAGR of 10.9% during (2023 - 2030). Additionally, The Mexico market would display a CAGR of 9.9% during (2023 - 2030).
Based on Product, the market is segmented into Imaging Systems, Transducer, Lasers, and Others. Based on End User, the market is segmented into Diagnostic Imaging Centers, Hospitals, and Others. Based on Type, the market is segmented into Microscopy, and Tomography. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Photoacoustic Imaging Market is Projected to reach USD 164.1 Million by 2030, at a CAGR of 9.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fujifilm Holdings Corporation, Advantest Corporation, Prexion Corporation, Seno Medical Instruments, Inc., illumiSonics, Inc., OPOTEK LLC, EKSLPA (EKSMA Group), Verasonics, Inc., Photosound Technologies, Inc., iThera Medical GmbH.
By Product
By End User
By Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
